K230284 is an FDA 510(k) clearance for the Penumbra LP Coil System. This device is classified as a Device, Neurovascular Embolization (Class II - Special Controls, product code HCG).
Submitted by Penumbra, Inc. (Alameda, US). The FDA issued a Cleared decision on October 25, 2023, 265 days after receiving the submission on February 2, 2023.
This device falls under the Neurology FDA review panel. Regulated under 21 CFR 882.5950.
| 510(k) Number | K230284 FDA.gov |
| FDA Decision | Cleared Substantially Equivalent - Traditional 510(k) (SESE) |
| Date Received | February 02, 2023 |
| Decision Date | October 25, 2023 |
| Days to Decision | 265 days |
| Submission Type | Traditional |
| Review Panel | Neurology (NE) |
| Summary | Summary PDF |
| Product Code | HCG — Device, Neurovascular Embolization |
| Device Class | Class II - Special Controls |
| CFR Regulation | 21 CFR 882.5950 |